^
BIOMARKER:

FGFR2 mutation

i
Other names: FGFR2, BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25, Fibroblast growth factor receptor 2
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
FGFR2 mutation
Urothelial Cancer
erdafitinib
Sensitive
:
A1
FGFR2 mutation
Cholangiocarcinoma
erdafitinib
Sensitive
:
C1
FGFR2 mutation
Gastric Cancer
erdafitinib
Sensitive
:
C1
FGFR2 mutation
Cholangiocarcinoma
infigratinib
Sensitive
:
C2
FGFR2 mutation
Cholangiocarcinoma
ARQ 087
Sensitive
:
C2
FGFR2 mutation
Cholangiocarcinoma
TAS 120
Sensitive
:
C2
FGFR2 mutation
Cholangiocarcinoma
TT-00420
Sensitive
:
C2
FGFR2 mutation
Non Small Cell Lung Cancer
Immunotherapy
Sensitive
:
C3
FGFR2 mutation
Non Small Cell Lung Cancer
nintedanib
Sensitive
:
C3
FGFR2 mutation
Cholangiocarcinoma
pemigatinib
Sensitive
:
C3
FGFR2 mutation
Cholangiocarcinoma
FGFR2 inhibitor
Resistant
:
C3
FGFR2 mutation
Cholangiocarcinoma
Debio 1347
Sensitive
:
C3
FGFR2 mutation
Solid Tumor
CPL304110
Sensitive
:
D
FGFR2 mutation
Multiple Myeloma
infigratinib
Sensitive
:
D
FGFR2 mutation
Endometrial Cancer
infigratinib
Sensitive
:
D
FGFR2 mutation
Endometrial Cancer
PD 0173074
Sensitive
:
D
FGFR2 mutation
Endometrial Cancer
TKI258
Sensitive
:
D
FGFR2 mutation
Estrogen Receptor Positive Breast Cancer
fulvestrant
Resistant
:
D
FGFR2 mutation
Estrogen Receptor Positive Breast Cancer
palbociclib
Resistant
:
D
FGFR2 mutation
Solid Tumor
eFT226
Sensitive
:
D
FGFR2 mutation
Gastric Cancer
KIN-3248
Sensitive
:
D
FGFR2 mutation
Cholangiocarcinoma
KIN-3248
Sensitive
:
D
FGFR2 mutation
Urothelial Cancer
erdafitinib
Resistant
:
D